Sales Growth YoY (Last Twelve Months): vTv Therapeutics Inc. (VTVT)

Graphic logo of vTv Therapeutics, Inc. (VTVT)

vTv Therapeutics Inc. (VTVT) is developing TTP399 to stabilize blood sugar levels in type 1 diabetes. Current year-over-year (TTM) sales dynamics exhibit volatility, where the parameter equals 215621.60. Management is mitigating risks by seeking partners for final testing. However, high R&D expenditures are creating negative operating leverage, which is constraining the company's financial growth.

Sales Growth YoY (Last Twelve Months): vtvtherapeutics.com (VTVT) for 02/11/2024 - 11/19/2026

vTv Therapeutics Inc - analytical breakdowns and key metrics (VTVT)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Fundamental company valuation:vTv Therapeutics, Inc. VTVT
Mass-produced product of vTv Therapeutics, Inc.

This metric measures the percentage change in revenue over the last twelve months, neutralizing seasonality and short-term market fluctuations. This metric allows for an assessment of the real speed of business scaling and the effectiveness of product commercialization. By analyzing the annual change in revenue using the TTM method, an investor can see the company's expansion rates. For vTv Therapeutics Inc. (VTVT), this growth confirms the monetization of patents in the diabetes sector. A protected niche and FDA barriers make sales dynamics a key indicator of business resilience.

Competitor analysis for vTv Therapeutics Inc.

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) crinetics.com (CRNX)|Revenue Growth YoY (Last 12 Months) newamsterdampharma.com NAMS|Sales Growth YoY (Last Twelve Months) Soleno Therapeutics Inc SLNO|Sales Growth YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) MiMedx Group, Inc.|Sales Growth YoY (Last Twelve Months) Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) MBX|Revenue Growth YoY (Last 12 Months) Altimmune, Inc. ALT|Sales Growth YoY (TTM) AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Trailing Twelve Months Revenue Growth|BIOA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) BMEA (Biomea Fusion)|QNCX (quincetx.com) - Revenue Growth YoY (Last 12 Months)|Fractyl - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Agape ATP Corp.|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)